candesartan cilexetil has been researched along with Cardiac Remodeling, Ventricular in 13 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both celiprolol and candesartan showed cardioprotective effects in this heart failure model." | 7.73 | Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. ( Hayashi, T; Kitaura, Y; Matsumura, Y; Mori, T; Ohkita, M; Okuda, N; Shimomura, H; Sohmiya, K; Yoshikawa, J; Yoshiyama, M, 2005) |
| "Both celiprolol and candesartan showed cardioprotective effects in this heart failure model." | 3.73 | Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. ( Hayashi, T; Kitaura, Y; Matsumura, Y; Mori, T; Ohkita, M; Okuda, N; Shimomura, H; Sohmiya, K; Yoshikawa, J; Yoshiyama, M, 2005) |
| "Because the effects of an aldosterone receptor antagonist on transcriptional factors and mRNA expression have not been fully examined in myocardial infarction (MI), the present study examined the effects of spironolactone (SPIRO) and candesartan cilexitil (CAN) on activation of activator protein-1 (AP-1), nuclear factor-kappaB (NF-kappaB) and mRNA expression in the non-ischemic myocardium after MI." | 3.72 | Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction. ( Akioka, K; Iwao, H; Izumi, Y; Kim, S; Matsumoto, R; Nakamura, Y; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M, 2004) |
| "To investigate the long-term effects of TCV116 (candesartan cilexetil) on cardiac function changes after myocardial infarction." | 3.72 | [Long-term effects of TCV116 on cardiac function changes after myocardial infarction]. ( Tao, ZW; Wang, Y; Wang, YW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (92.31) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Niu, Q | 1 |
| Peng, X | 1 |
| Li, M | 1 |
| Liu, K | 1 |
| Liu, Y | 1 |
| Liu, J | 1 |
| Jin, F | 1 |
| Li, X | 1 |
| Wei, Y | 1 |
| Yamane, T | 1 |
| Fujii, Y | 1 |
| Orito, K | 1 |
| Osamura, K | 1 |
| Kanai, T | 1 |
| Wakao, Y | 1 |
| Goineau, S | 1 |
| Nisse-Durgeat, S | 1 |
| Pape, D | 1 |
| Guillo, P | 1 |
| Ramée, MP | 1 |
| Bellissant, E | 1 |
| Matsumoto, R | 2 |
| Yoshiyama, M | 3 |
| Omura, T | 2 |
| Kim, S | 1 |
| Nakamura, Y | 1 |
| Izumi, Y | 2 |
| Akioka, K | 2 |
| Iwao, H | 2 |
| Takeuchi, K | 2 |
| Yoshikawa, J | 3 |
| Jones, ES | 1 |
| Black, MJ | 1 |
| Widdop, RE | 1 |
| Tao, ZW | 1 |
| Wang, YW | 1 |
| Wang, Y | 1 |
| Mori, T | 1 |
| Hayashi, T | 1 |
| Sohmiya, K | 1 |
| Okuda, N | 1 |
| Shimomura, H | 1 |
| Ohkita, M | 1 |
| Matsumura, Y | 1 |
| Kitaura, Y | 1 |
| Kusuyama, T | 2 |
| Nishiya, D | 1 |
| Enomoto, S | 1 |
| Suzuki, H | 1 |
| Omori, Y | 1 |
| Soda, T | 1 |
| Tsunoda, F | 1 |
| Sato, T | 1 |
| Shoji, M | 1 |
| Iso, Y | 1 |
| Kondo, T | 1 |
| Koba, S | 1 |
| Geshi, E | 1 |
| Katagiri, T | 1 |
| Higashi, T | 1 |
| Kobayashi, N | 4 |
| Hara, K | 3 |
| Shirataki, H | 1 |
| Matsuoka, H | 4 |
| Nakano, S | 1 |
| Mori, Y | 1 |
| Tsubokou, Y | 2 |
| Watanabe, S | 1 |
| Nishikimi, T | 1 |
| Horinaka, S | 1 |
| Ishimitsu, T | 1 |
1 trial available for candesartan cilexetil and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Comparison of the effects of candesartan cilexetil and enalapril maleate on right ventricular myocardial remodeling in dogs with experimentally induced pulmonary stenosis.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Constriction, Pathologic; Dog | 2008 |
12 other studies available for candesartan cilexetil and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Candesartan cilexetil attenuated cardiac remodeling by improving expression and function of mitofusin 2 in SHR.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Gene E | 2016 |
Systemic and regional hemodynamic and cardiac remodeling effects of candesartan in dilated cardiomyopathic hamsters with advanced congestive heart failure.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 2002 |
Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.
Topics: Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Collagen Type I; Collagen Ty | 2004 |
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Block | 2004 |
[Long-term effects of TCV116 on cardiac function changes after myocardial infarction].
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Heart Failure; | 2004 |
Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Celiprolol; Disease Models, An | 2005 |
Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chemokine CCL2 | 2005 |
Inhibitory effect of candesartan cilexetil on left ventricular remodeling after myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; B | 2006 |
Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Bo | 2000 |
Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; | 2001 |
Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv | 2001 |
Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats.
Topics: Adrenomedullin; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Disea | 2001 |